HEADER TRANSFERASE 14-FEB-05 1YUL TITLE CRYSTAL STRUCTURE OF NICOTINIC ACID MONONUCLEOTIDE ADENYLYLTRANSFERASE TITLE 2 FROM PSEUDOMONAS AERUGINOSA COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROBABLE NICOTINATE-NUCLEOTIDE ADENYLYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NICOTINIC ACID MONONUCLEOTIDE ADENYLYLTRANSFERASE, NAMN AT, COMPND 5 DEAMIDO-NAD+, PYROPHOSPHORYLASE, DEAMIDO-NAD+, DIPHOSPHORYLASE, COMPND 6 NICOTINATE MONONUCLEOTIDE ADENYLYLTRANSFERASE, NAMN COMPND 7 ADENYLYLTRANSFERASE; COMPND 8 EC: 2.7.7.18; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 287; SOURCE 4 GENE: NADD (PA4006); SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: C41(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-28B(+) KEYWDS ALPHA/BETA DOMAIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR H.J.YOON,H.L.KIM,B.MIKAMI,S.W.SUH REVDAT 3 30-OCT-24 1YUL 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 1YUL 1 VERSN REVDAT 1 08-NOV-05 1YUL 0 JRNL AUTH H.J.YOON,H.L.KIM,B.MIKAMI,S.W.SUH JRNL TITL CRYSTAL STRUCTURE OF NICOTINIC ACID MONONUCLEOTIDE JRNL TITL 2 ADENYLYLTRANSFERASE FROM PSEUDOMONAS AERUGINOSA IN ITS APO JRNL TITL 3 AND SUBSTRATE-COMPLEXED FORMS REVEALS A FULLY OPEN JRNL TITL 4 CONFORMATION JRNL REF J.MOL.BIOL. V. 351 258 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 16009375 JRNL DOI 10.1016/J.JMB.2005.06.001 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 9.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 128706.740 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 30151 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.700 REMARK 3 FREE R VALUE TEST SET COUNT : 2917 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.12 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4368 REMARK 3 BIN R VALUE (WORKING SET) : 0.2280 REMARK 3 BIN FREE R VALUE : 0.2770 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 496 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.012 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1647 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 13 REMARK 3 SOLVENT ATOMS : 189 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.06000 REMARK 3 B22 (A**2) : 0.06000 REMARK 3 B33 (A**2) : -0.12000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.20 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.110 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.940 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 5.080 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 7.610 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.47 REMARK 3 BSOL : 68.10 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : CIT.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : CIT.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1YUL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-FEB-05. REMARK 100 THE DEPOSITION ID IS D_1000031934. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-NOV-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-18B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791, 0.9793, 0.9500 REMARK 200 MONOCHROMATOR : GE(111) CRYSTALS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31029 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.600 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 7.70 REMARK 200 R MERGE FOR SHELL (I) : 0.32500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 11.50 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: BIS-TRIS PROPANE, TRISODIUM CITRATE, REMARK 280 GLYCEROL , PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+1/4 REMARK 290 8555 -Y,-X,-Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.17000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 82.75500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 27.58500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 55.17000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 27.58500 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 82.75500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 1 CHAIN. THE BIOLOGICAL UNIT IS NOT REMARK 300 ASSIGNED. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 212 REMARK 465 PRO A 213 REMARK 465 HIS A 214 REMARK 465 LEU A 215 REMARK 465 GLU A 216 REMARK 465 HIS A 217 REMARK 465 HIS A 218 REMARK 465 HIS A 219 REMARK 465 HIS A 220 REMARK 465 HIS A 221 REMARK 465 HIS A 222 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 69 -13.29 77.25 REMARK 500 PRO A 135 -34.29 -39.35 REMARK 500 ALA A 137 147.30 -173.30 REMARK 500 SER A 139 71.15 -63.38 REMARK 500 GLU A 140 89.05 -165.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A 230 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1YUM RELATED DB: PDB REMARK 900 THA SAME PROTEIN WITH CITRIC ACID AND NICOTINATE MONONUCLEOTIDE REMARK 900 RELATED ID: 1YUN RELATED DB: PDB REMARK 900 THA SAME PROTEIN WITH ADENOSINE-5'-TRIPHOSPHATE AND MG DBREF 1YUL A 1 214 UNP Q9HX21 NADD_PSEAE 1 214 SEQADV 1YUL MET A -19 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL GLY A -18 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL SER A -17 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL SER A -16 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL HIS A -15 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL HIS A -14 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL HIS A -13 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL HIS A -12 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL HIS A -11 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL HIS A -10 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL SER A -9 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL SER A -8 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL GLY A -7 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL LEU A -6 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL VAL A -5 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL PRO A -4 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL ARG A -3 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL GLY A -2 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL SER A -1 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL HIS A 0 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL MSE A 20 UNP Q9HX21 MET 20 MODIFIED RESIDUE SEQADV 1YUL MSE A 26 UNP Q9HX21 MET 26 MODIFIED RESIDUE SEQADV 1YUL MSE A 59 UNP Q9HX21 MET 59 MODIFIED RESIDUE SEQADV 1YUL MSE A 104 UNP Q9HX21 MET 104 MODIFIED RESIDUE SEQADV 1YUL LEU A 215 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL GLU A 216 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL HIS A 217 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL HIS A 218 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL HIS A 219 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL HIS A 220 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL HIS A 221 UNP Q9HX21 EXPRESSION TAG SEQADV 1YUL HIS A 222 UNP Q9HX21 EXPRESSION TAG SEQRES 1 A 242 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 242 LEU VAL PRO ARG GLY SER HIS MET GLY LYS ARG ILE GLY SEQRES 3 A 242 LEU PHE GLY GLY THR PHE ASP PRO VAL HIS ILE GLY HIS SEQRES 4 A 242 MSE ARG SER ALA VAL GLU MSE ALA GLU GLN PHE ALA LEU SEQRES 5 A 242 ASP GLU LEU ARG LEU LEU PRO ASN ALA ARG PRO PRO HIS SEQRES 6 A 242 ARG GLU THR PRO GLN VAL SER ALA ALA GLN ARG LEU ALA SEQRES 7 A 242 MSE VAL GLU ARG ALA VAL ALA GLY VAL GLU ARG LEU THR SEQRES 8 A 242 VAL ASP PRO ARG GLU LEU GLN ARG ASP LYS PRO SER TYR SEQRES 9 A 242 THR ILE ASP THR LEU GLU SER VAL ARG ALA GLU LEU ALA SEQRES 10 A 242 ALA ASP ASP GLN LEU PHE MSE LEU ILE GLY TRP ASP ALA SEQRES 11 A 242 PHE CYS GLY LEU PRO THR TRP HIS ARG TRP GLU ALA LEU SEQRES 12 A 242 LEU ASP HIS CYS HIS ILE VAL VAL LEU GLN ARG PRO ASP SEQRES 13 A 242 ALA ASP SER GLU PRO PRO GLU SER LEU ARG ASP LEU LEU SEQRES 14 A 242 ALA ALA ARG SER VAL ALA ASP PRO GLN ALA LEU LYS GLY SEQRES 15 A 242 PRO GLY GLY GLN ILE THR PHE VAL TRP GLN THR PRO LEU SEQRES 16 A 242 ALA VAL SER ALA THR GLN ILE ARG ALA LEU LEU GLY ALA SEQRES 17 A 242 GLY ARG SER VAL ARG PHE LEU VAL PRO ASP ALA VAL LEU SEQRES 18 A 242 ASN TYR ILE GLU ALA HIS HIS LEU TYR ARG ALA PRO HIS SEQRES 19 A 242 LEU GLU HIS HIS HIS HIS HIS HIS MODRES 1YUL MSE A 20 MET SELENOMETHIONINE MODRES 1YUL MSE A 26 MET SELENOMETHIONINE MODRES 1YUL MSE A 59 MET SELENOMETHIONINE MODRES 1YUL MSE A 104 MET SELENOMETHIONINE HET MSE A 20 8 HET MSE A 26 8 HET MSE A 59 8 HET MSE A 104 8 HET CIT A 230 13 HETNAM MSE SELENOMETHIONINE HETNAM CIT CITRIC ACID FORMUL 1 MSE 4(C5 H11 N O2 SE) FORMUL 2 CIT C6 H8 O7 FORMUL 3 HOH *189(H2 O) HELIX 1 1 HIS A 16 PHE A 30 1 15 HELIX 2 2 PRO A 43 GLU A 47 5 5 HELIX 3 3 SER A 52 ALA A 65 1 14 HELIX 4 4 TYR A 84 ALA A 94 1 11 HELIX 5 5 TRP A 108 CYS A 112 1 5 HELIX 6 6 GLY A 113 TRP A 117 5 5 HELIX 7 7 ARG A 119 HIS A 126 5 8 HELIX 8 8 PRO A 142 SER A 144 5 3 HELIX 9 9 LEU A 145 SER A 153 1 9 HELIX 10 10 ASP A 156 LEU A 160 5 5 HELIX 11 11 SER A 178 ALA A 188 1 11 HELIX 12 12 PRO A 197 HIS A 207 1 11 SHEET 1 A 6 LEU A 70 VAL A 72 0 SHEET 2 A 6 GLU A 34 PRO A 39 1 N LEU A 37 O THR A 71 SHEET 3 A 6 ARG A 4 GLY A 10 1 N PHE A 8 O ARG A 36 SHEET 4 A 6 GLN A 101 GLY A 107 1 O GLN A 101 N ILE A 5 SHEET 5 A 6 HIS A 128 GLN A 133 1 O VAL A 130 N MSE A 104 SHEET 6 A 6 ILE A 167 TRP A 171 1 O VAL A 170 N GLN A 133 LINK C HIS A 19 N MSE A 20 1555 1555 1.33 LINK C MSE A 20 N ARG A 21 1555 1555 1.33 LINK C GLU A 25 N MSE A 26 1555 1555 1.33 LINK C MSE A 26 N ALA A 27 1555 1555 1.33 LINK C ALA A 58 N MSE A 59 1555 1555 1.33 LINK C MSE A 59 N VAL A 60 1555 1555 1.33 LINK C PHE A 103 N MSE A 104 1555 1555 1.33 LINK C MSE A 104 N LEU A 105 1555 1555 1.33 CISPEP 1 ASP A 13 PRO A 14 0 0.20 SITE 1 AC1 7 HIS A 16 HIS A 19 VAL A 177 SER A 178 SITE 2 AC1 7 ALA A 179 THR A 180 HOH A 487 CRYST1 65.525 65.525 110.340 90.00 90.00 90.00 P 43 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015261 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015261 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009063 0.00000